Skip to main content
. 2020 Mar 13;14(7):1529–1537. doi: 10.1002/1878-0261.12658

Fig. 1.

Fig. 1

Immunomodulators used in ongoing/past clinical trials, in combination with radiotherapy/chemoradiotherapy. For each immunotherapy category, main drug names and the tumour sites investigated are listed.